Endocrinology and Metabolic Disorders Market Analysis
Cost-effectiveness, Advanced Technology, Rising Demand Pushes the Insulin Delivery Devices Market
Fresenius Kabi introduced Bivalirudin...

Fresenius Kabi introduced Bivalirudin for Injection Fresenius Kabi announced that it has introduced Bivalir...

Biosimilar Market in India

Today's opportunity for Indian companies in biosimilars is not much different from that of the generics ind...

Boston Biomedical starts phase III; M...

Boston Biomedical starts phase III study of Napabucasin Boston Biomedical, an industry leader in the develo...

Sun Pharma & ICGEB announce collaboration; Boehringer Ingelheim and Lupin Sign deal; Daiichi...

Sun Pharma & ICGEB announce exclusive collaboration to develop novel dengue vaccine International Centre for Genetic Engineering and Biotechnology (ICGEB) and Sun Pharma Ltd. announced their ne...


Lupin acquired; FDA grants approval; NATCO gets approval; Wockhardt Ltd. gets import alert; Paten...

Branded product portfolio of Shionogi acquired by Lupin Pharma giant Lupin entered into a strategic agreement when its Japanese subsidiary Kyowa Pharmaceutical Industry Co. purchased the product po...


Default Blog Image
Nonalcoholic Steatohepatitis (NASH) – Market Insights, Epidemiology and Market Forecast-2020

DelveInsight is a leading Business Consultant and Market Research Firm which has become the knowledge partner for biotechnology and pharmaceutical companies by providing competitive intelligence in...


Default Blog Image
Small interfering RNA (siRNA) Therapeutics

In the years since the discovery of RNA interference, researchers have found that this process is far more widespread than we might expect, and that small pieces of RNA play many functional roles. ...


Default Blog Image
DelveInsight’s Metabolic disorders based Gene Therapy Reports

Gene Therapy to “reverse” Metabolic disorders!Metabolic disorders are collectively common, frequently severe and in many instances difficult or impossible to treat. Accordingly, there is a compe...


Default Blog Image
EMA Biosimilars Approvals

In the European Union (EU), a legal framework for approving biosimilars was established in 2003. This framework means that biosimilars can only be approved centrally via the European Medicines Age...


Digital Health in the Field of Oncology
A Growing World of Digita...

Digital health technologies can fill the current gaps in oncology care while rebalancing the existin.....

Gout Newsletter
Gout

Gout is a chronic disease caused by the deposition of monosodium urate (MSU) crystals in joints. It .....

Neurofibromatosis Newsletter
Neurofibromatosis...

Neurofibromatosis is a progressive and autosomal dominant inherited disorder of the nervous system w.....

Editor's Pick
An in-depth Assessment of the Top Drugs Launched by Leading Global Companies ...

Progress is driven by innovation. When it comes to developing novel medications and the...

Changing Dynamics of HIV-1 Treatment Market

The HIV-1 treatment market for naïve and experienced patients is evolving consistently....

Which Countries Top the Chart in Global Pharmaceutical Market?

The Pharmaceuticals segment of the Healthcare Industry has a significant market across ...

von Willebrand disease (VWD) – Misdiagnosis Still Prevalent!

Von Willebrand disease is a type of blood disorder that causes the blood to clot improp...

Analyzing the Key Companies and the Emerging Gene Therapy in the Dermatology ...

Advances in genetics research have sparked a surge in interest in gene therapy in derma...